Publications

Sequential Therapies After Atezolizumab plus Bevacizumab or Lenvatinib First-Line Treatments in Advanced Hepatocellular Carcinoma

AuthID
P-00Z-GG2

Author(s)

Persano, M

Rimini, M

Tada, T

Suda, G

Shimose, S

Kudo, M

Cheon, J

Finkelmeier, F

Presa, J

Masi, G

Yoo, C

Lonardi, S

Piscaglia, F

Iavarone, MA

Tamburini, E

Cabibbo, G

Silletta, M

Cascinu, S

Scartozzi, M

Gardini, AC

Document Type

Abstract

Year published

2023

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 34, Pages: S603-S604 (2)

Conference

Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: OCT 20-24, 2023, Location: Barcelona, SPAIN

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2023.09.2117

Wos: WOS:001087480201303

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Sequential Therapies After Atezolizumab plus Bevacizumab or Lenvatinib First-Line Treatments in Advanced Hepatocellular Carcinoma

Useful Links

Get Help

Federated Authentication (Click on the image)

Sequential Therapies After Atezolizumab plus Bevacizumab or Lenvatinib First-Line Treatments in Advanced Hepatocellular Carcinoma

Useful Links

Get Help